Kemnay Advisory Services’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$62.6K Buy
657
+41
+7% +$4.38K 0.01% 241
2026
Q2
$68.4K Buy
616
+54
+10% +$4.88K 0.01% 227
2026
Q1
$48.9K Buy
562
+355
+171% +$34.5K 0.01% 266
2025
Q4
$22.2K Buy
+207
New +$22K ﹤0.01% 509

Other funds holding RYTM

Kemnay Advisory Services's RYTM Position: Q3 2026 in Review

Kemnay Advisory Services increased its Rhythm Pharmaceuticals (RYTM) stake by 6.7% in Q3 2026, buying an estimated $4.38K and bringing the position to 657 shares worth $62.6K. The position accounts for 0.01% of the portfolio, ranked #241.

Kemnay Advisory Services first reported a position in RYTM in Q4 2025 and has held it in 4 quarters since. The position peaked at $68.4K in Q2 2026. 333 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.

  • Kemnay Advisory Services held 657 shares of Rhythm Pharmaceuticals worth $62.6K as of Q3 2026.
  • Kemnay Advisory Services bought 41 Rhythm Pharmaceuticals shares in Q3 2026, an estimated $4.38K.
  • Rhythm Pharmaceuticals made up 0.01% of Kemnay Advisory Services's portfolio in Q3 2026, its #241 holding.
  • Kemnay Advisory Services first reported a position in Rhythm Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • Kemnay Advisory Services's Rhythm Pharmaceuticals position peaked at $68.4K in Q2 2026.
  • 333 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.

Based on Kemnay Advisory Services's 13F filing for Q3 2026, filed 16 Nov 2026.